US 11878062
Multimeric T-cell modulatory polypeptides and methods of use thereof
granted A61KA61K2039/605A61K2039/6056
Quick answer
US patent 11878062 (Multimeric T-cell modulatory polypeptides and methods of use thereof) held by Cue Biopharma, Inc. expires Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Cue Biopharma, Inc.
- Grant date
- Tue Jan 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K2039/605, A61K2039/6056, A61K39/001114, A61K39/001153